The new service, which is led by the team of consultant cardiothoracic radiologists behind Heart & Lung Health, uses low-dose CT scanning to detect subtle signs of early lung cancer in their earliest stage when most curable. In addition, it can be used to spot other lung abnormalities, such as damage caused by a Covid-19 infection.
The scans are performed by the Queen Square Imaging Centre and use a fraction of the radiation dose of a standard CT scan but can detect signs of disease which may be invisible on conventional chest x-ray.
The screening service is aimed at higher-risk patients, including smokers, those who have stopped smoking within the last 15 years and individuals with a family history of lung cancer.
In cases where abnormalities are detected, they can be categorised and analysed using AI technology, which can measure the amount of emphysema present in the lungs and determine the most appropriate treatment for small lung nodules.
Jodee Cooper, CEO of QS Enterprises, the charitable organisation that operates the Queen Square Imaging Centre said: ‘We are delighted to make lung health assessment available to patients in London and beyond with this new service. Whilst our focus has typically always been imaging for neurological and neurosurgical conditions owing to our co-location with the renowned National Hospital for Neurology and Neurosurgery, our facilities are well equipped to support all patients. We are well accustomed to working with top specialists to offer truly world-class care that is convenient and accessible to all. The expertise that the Heart & Lung Health team bring to this service has enabled us to develop an innovative service which will result in earlier lung cancer diagnosis and better outcomes for patients at high risk.’